IndraLab

Statements


USP8 activates LRIG1. 4 / 4
| 4

reach
"These results suggest that simultaneous blockage of USP8 may further enhance LRIG1 dependent Met degradation and subsequent tumor growth inhibition by SAIT301 and other Met targeting drugs that have a similar mechanism of action."

reach
"This result suggests that SAIT301 perturbs USP8 mediated modulation of LRIG1, resulting in the degradation of LRIG1."

reach
"Over-expression of USP8 substantially reduced the LRIG1 degradation (XREF_FIG)."

reach
"Moreover, we showed that suppression of USP8 activity, by over-expression of USP8-CS, led to enhancement of the anti-tumor activity of Met targeting therapeutic antibody by promoting degradation of both Met and LRIG1."